Modeling Down syndrome screening performance using first-trimester serum markers.
Ultrasound Obstet Gynecol 38(2):134-9 (2011) PMID 21800388
To evaluate the modeled predictive value of three current screening markers (pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotropin (free β-hCG), and nuchal translucency (NT)) and four potential screening markers (a disintegrin and metalloprotease 12 (ADAM12), total hCG, placental protein 13 (PP13), and placental growth factor (PlGF)) for Down syndrome using different screening strategies.
DOI: 10.1002/uog.8881
Version: za2963e q8zae q8zb5 q8zcc q8zd2 q8zec q8zf5 q8zga